Known or suspected allergy or hypersensitivity to the study drug
Known prior or suspected hypersensitivity to investigational products
Patients with known hypersensitivity to perflutren
Known hypersensitivity to study drug and/or drug class
Has a known hypersensitivity to any of the study therapy products
Known hypersensitivity to any study drug used in this trial
Known hypersensitivity to any study drug
Known or suspected hypersensitivity to ruxolitinib.
Known hypersensitivity to any study drug
Known hypersensitivity to any component of the investigational products; known hypersensitivity to salicylates; known hypersensitivity to aspartame-containing products for patients with phenylketonuria; known allergies to any of the medications or components of medications used in the trial
Known hypersensitivity to any study drug
Known hypersensitivity to acyclovir or similar anti-viral drug
Has a known hypersensitivity to any of the study therapy products
Known hypersensitivity to trial drug
Known hypersensitivity to acyclovir or similar anti-viral drug
Known prior or suspected hypersensitivity to investigational products.
Hypersensitivity to acyclovir or similar anti-viral drug
Known hypersensitivity to any study drug
Patients with known or suspected hypersensitivity to perflutren
History of hypersensitivity to Definity (perflutren lipid microsphere) or Lumason
Known hypersensitivity to sulfur hexafluoride or to any component of perflutren lipid (Definity)
Known hypersensitivity to any component of perflutren lipid (Definity)
Hypersensitivity to perflutren
Known hypersensitivity to perflutren (if the patient has been exposed to perflutren in the past and had an allergic reaction)
Women with known cardiac shunt, pulmonary hypertension or hypersensitivity to perflutren agent
Patients with known or suspected hypersensitivity to perflutren
Patients with any known hypersensitivity to perflutren agent
Patients with known hypersensitivity to perflutren
Patients with known hypersensitivity to perflutren
Known or suspected: hypersensitivity to perflutren, blood, blood products or albumin
Known or suspected: hypersensitivity to a prior perflutren protein-type A microspheres (OPTISON) administration
